
































































Gum Acacia supplementation improves adiponectin levels and HbA1c/adiponectin ratio in women with type 2 diabetes: A randomized controlled trial
							| Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007



	

				
						
 
	Skip to main content
	Skip to main navigation menu
		Skip to site footer


			

				
					
						Open Menu
					
										
																Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007
										

				


				
				
					
					
						
																					
				
					Home
				
										
									
										Food Science Publisher
									
								
	
									
										Functional Food Center
									
								


							
	
				
					Current
				
							
	
				
					Archives
				
							
	
				
					About
				
										
									
										About the Journal
									
								
	
									
										Aims and Scope
									
								
	
									
										Contact
									
								
	
									
										Editing Services
									
								
	
									
										Editorial Team
									
								
	
									
										Express Peer Review
									
								
	
									
										Graphical Abstract
									
								
	
									
										Journal Insights
									
								
	
									
										Privacy Statement
									
								
	
									
										Submissions
									
								


							
	
				
					Announcements
				
							
	
				
					Search
				
							



				

																						
									
										
										Search
									
								

													

					

					
								
				
					Register
				
							
	
				
					Login
				
							



					

				
			

		

						
			
				


			
		
			
				Home
			
			/
		
	
			
				Archives
			
			/
		
	
				
					Vol. 15 No. 3 (2025): March 2025
				
				/
			
	
			
									Clinical Trial
							
		



	
		  	 

		
	
		Gum Acacia supplementation improves adiponectin levels and HbA1c/adiponectin ratio in women with type 2 diabetes: A randomized controlled trial
	


	
	
		

							
					Authors

						
							
								Rasha Babiker
							
																																		
	
							
								Ibrahim Abdelrhim Ali 
							
																																		
	
							
								Tarig H. Merghani 
							
																																		
	
							
								Amin SI Banaga 
							
																																		
	
							
								Nada Tawfig Hashim 
							
																																		
	
							
								Mohammed Seed Ahmed 
							
																																		
	
							
								Amal M. Saeed 
							
																																		


				
			
																	
					
												DOI:
					

					
						
							https://doi.org/10.31989/ffhd.v15i3.1568
						
					
				
			

						
										
					Abstract

					Background: Adiponectin contributes to the regulation of glucose homeostasis and lipid profiles and plays a role in maintaining average body weight. At high serum concentrations, adiponectin sensitizes cells to insulin and exerts favorable effects on type 2 diabetes patients. Gum Acacia (GA) has shown beneficial impacts on serum glucose and lipid profile in both humans and animals. This study aimed to test the effects of oral GA consumption on serum adiponectin levels, glycemic parameters, and the glycosylated hemoglobin/adiponectin ratio in diabetic women.

Methods: Seventy-three diabetic women (type 2) with an HbA1c ≥ 6.5% were participated in a randomized, double-blind, placebo-controlled clinical trial. The intervention group (34 patients) received 30.0 g per day of GA, whereas the control group (39 patients) received 5.0 g of placebo per day. The intervention period was 12 weeks. Participants were interviewed and examined clinically before, during and after the intervention. The parameters analyzed before and after the intervention were BMI, serum adiponectin, fasting blood glucose, HbA1c, and the HbA1c/adiponectin ratio. 

Results: Before the intervention, the mean age was 49±1.1 years, BMI was 28.3±0.6 kg/m2, HbA1c was 8.8±0.3%, adiponectin was 5.4±0.12 µg/ml, and the HbA1c/Adiponectin ratio was 1.8±0.06. All baseline parameters showed nonsignificant differences between the intervention and placebo groups. Following GA administration, both BMI and HbA1c were significantly reduced by 2.5% and 3.8%, respectively. The mean serum adiponectin level significantly increased by 7.4% from baseline in the GA group. The mean change in the HbA1c/adiponectin ratio was 0.3 µg/ml following the intervention (P < 0.01). Compared to that in the placebo group, the HbA1c/adiponectin ratio significantly decreased by 16.6% from baseline in the GA group versus an insignificant increase of 25.2% in the placebo group. 

Conclusions: Gum Acacia consumption improved the glycemic profile and increased the serum adiponectin concentration in diabetic women at a dosage of 30.0 g/day for three months. This study uniquely explores the impact of Gum Acacia (GA) on serum adiponectin levels and the HbA1c/adiponectin ratio in type 2 diabetic women. Demonstrating a significant increase in adiponectin and a reduction in the HbA1c/adiponectin ratio following GA supplementation, this study provides novel insights into GA's potential as a dietary intervention for improving glycemic control in diabetic populations. 

Keywords: Gum Acacia, Adiponectin, Dietary intervention, Type 2 diabetes mellitus

				
			
			

						
																																																													
						
		


		

						
										
					
						Downloads
					

						
								
	
													


		
	[Abstract]

	
							
	
								
	
													


		
	[Full Article]

	
							


				

						
						
				
					
						Published
					

					
																			2025-03-19
																	

				
							

			
						
										

											
							
								Issue
							

							
								
									Vol. 15 No. 3 (2025): March 2025
								
							

						
					
											
							
								Section
							

							
								Clinical Trial
							

						
					
									

			
						
										
					
						License
					

																										Copyright (c) 2025 Functional Foods in Health and Disease

														This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

																Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.

				

			
			

		

	




	




	


							



	

	

					
				About the Journal      Editing Services      Graphical Abstract      Journal Insights        Submissions        Editorial Team       Privacy Statement        Contact        Current        Archives

 

			

		
		Open Journal Systems Hosting and Support by: OpenJournalSystems.com


	










